Indegene wins nine $1 million-plus global content deals in Q2 FY27

Indegene Limited won nine Q2 FY27 deals with annual contract values of about $1 million, including an international content-platform migration mandate worth more than $5 million for an existing top-five customer. The October 30, 2026 earnings call showed the largest awards spanning global content operations, commercial services and GenAI-enabled delivery models.

What contracts did Indegene win in Q2 FY27?

Indegene won nine Q2 FY27 deals with annual contract values of about $1 million, including one worth more than $5 million and two in the $3 million to $5 million range. Management said Enterprise Commercial accounted for most of the activity, while further $1 million to $3 million contracts were divided between Enterprise Commercial and Enterprise Medical.

The largest award came from an existing top-five customer and extends a United States content-platform migration mandate that Indegene won in the prior quarter. The new work covers geographies outside the United States, began in Q3 FY27 and is expected to ramp up mainly in Q4 FY27 and later, according to management. That timing means the contract win does not necessarily translate immediately into reported revenue.

Why is Indegene's largest contract significant?

The more-than-$5-million contract expands an existing content-platform programme from the United States into additional markets. Indegene described the project as an increase in the scope of its prior-quarter mandate rather than a standalone pilot, indicating that the client added geographies after the initial platform work.

Indegene reported Q2 FY27 revenue of Rs 1,122.3 crore, up 39.5% year on year and 5.6% sequentially, while its top-five accounts grew 9.2% sequentially in rupee terms. The platform-migration award is with a top-five customer, but management also said one large client's quarterly revenue eased as Tectonic work ramped more gradually. The disclosed contract scope is therefore expanding faster than the immediate revenue ramp in at least some programmes.

The mandate also fits Indegene's stated push into multi-market content operations. Management did not disclose the number of new geographies, contract duration or a revenue-recognition schedule, but identified Q4 FY27 and later as the expected period for a more material ramp. That makes execution after the Q3 FY27 start the specific disclosed milestone for the award.

How did Indegene turn smaller work into larger mandates?

Indegene converted a prior change-management consulting assignment with a top-20 pharmaceutical company into a $3 million to $5 million mandate for a global content factory. The engagement will cover both Commercial and Medical content for the customer's international business, following what management had described in the previous quarter as a sub-$1-million starting assignment.

That progression provides the clearest period-to-period comparison in the deal disclosures: a focused consulting engagement in the prior quarter became a broader operating-model mandate one quarter later. Management characterized the sequence as first winning trust through a limited assignment and then taking on the customer's wider content operating model. It did not disclose the contract term, number of markets or expected revenue-recognition schedule.

The other $3 million to $5 million win came from a top-30 global pharmaceutical company for global digital-content management, replacing a large incumbent provider. Management said the deal has potential to expand but did not quantify future value. The top-30 award was a competitive displacement, whereas the top-20 content-factory mandate enlarged an existing Indegene relationship.

What role did Tectonic and Agentic AOR play in the wins?

Tectonic and Agentic Agency of Record, or Agentic AOR, formed part of Indegene's $1 million to $3 million deal activity in Q2 FY27. Tectonic is Indegene's GenAI-enabled model, while Agentic AOR is its AI-led agency model; management presented both as ways to extend content work into strategy, production and ongoing operations.

With its largest customer, Indegene added a Tectonic win for Canada after contracting Germany at the end of the last fiscal year and Spain in the prior quarter. This marked three markets in three successive quarters and the first disclosed expansion outside Europe. Management cautioned that the Canada rollout remains slow and said it is investing in change management and adoption across markets where the model has been sold.

A separate top-20 pharmaceutical client expanded an earlier pilot into a full-scale Agentic AOR engagement worth more than $1 million. The relationship began with Tectonic and then developed into the agency model, according to management. Indegene said this shows an engagement can begin in strategy, studio or production and later broaden upstream or downstream in the content chain.

How broad was Indegene's Q2 FY27 deal activity?

Indegene's nine disclosed wins covered commercial and medical work, different customer sizes and several delivery models. Beyond the three largest awards, it signed four additional $1 million to $3 million deals split evenly between Enterprise Commercial and Enterprise Medical, giving each segment two of those four contracts.

The company also disclosed additional work orders aggregating more than $3 million for a fast-growing United States emerging pharmaceutical customer. That client first partnered with Indegene in Q3 of the previous fiscal year for new-product launch support, and the new work orders continue those launch activities. Management presented this as an extension of an ongoing deal rather than identifying it as one of the nine new deal wins.

The broader client base expanded alongside the awards. Indegene had 107 active clients in Q2 FY27, 31 more than a year earlier; clients contributing more than $1 million annually increased to 59 from 54 in the prior quarter, while clients above $10 million increased to 13 from 12. These annual client-revenue cohorts differ from new-contract annual values, but they show an increase in larger customer relationships.

Conclusion

The Q2 FY27 disclosures show Indegene converting work across several formats into larger mandates. A United States platform programme expanded internationally, a prior-quarter consulting assignment became a global content-factory contract, and a pilot became an Agentic AOR engagement above $1 million. The nine wins spanned Enterprise Commercial and Enterprise Medical, with the three largest comprising one award above $5 million and two worth $3 million to $5 million.

The next item to watch is execution against management's disclosed timetable. Management said the largest international platform-migration mandate started in Q3 FY27 but should ramp more visibly in Q4 FY27 and beyond, while the Canada Tectonic programme is ramping slowly. Indegene also said its largest customer's Tectonic scope is expanding despite a gradual revenue ramp, leaving adoption and conversion into reported revenue as the unresolved issue.